1. Introduction {#sec1}
===============

Non-alcoholic fatty liver disease (NAFLD) is defined as accumulation of fat in the hepatic tissue which exceeds 5%--10% of its weight in the absence of substantial ethanol consumption and refers to a range of related disorders from simple hepatic steatosis to steatohepatitis, advanced fibrosis, as well as cirrhosis.[@bib1] Fatty liver and hepatic triglyceride accumulation possess a key role in the progression of different metabolic disorders like diabetes mellitus, obesity, insulin resistance, hypertension, as well as dyslipidemia indicating the pivotal contribution of management of NAFLD in health promotion.[@bib2] Recent evidence has fuelled concerns that NAFLD may be a new risk factor for extra-hepatic cancers.[@bib3] Currently, due to alterations in human\'s dietary regimen and life style, the incidence of NAFLD has been raised resulting in making this disease as one of the most common chronic diseases.[@bib4]

Limitations of conventional drugs have been considered useful in the management of NAFLD, including serious adverse effects, disease recurrence, and drug interaction lead to an extensive trend to novel resources of treatments. Natural drugs possess a long history of efficacious and safe usage in the traditional medicine of different nations. Recent investigations on nutritional aspects of fatty liver pathogenesis have focused on evaluating potential effects of herbal extracts and supplements as functional food ingredients in preventing hepatic lipid accumulation.[@bib5]

*Rosa damascena* Mill. from the family Rosaceae is commonly known as Damask rose. It has been found that more than 200 rose species and approximately 18000 cultivars of this herb have been identified.[@bib6] *R. damascena* is a perennial bushy shrub with cylindrical branches. The flowers are composite, colorful and showy. Its height is between 1 and 2 m. It has imparipinnate and compound leaf with 5--7 leaflets. Nowadays, this plant is widely cultivated across the world including Europe and Middle East countries, particularly in Iran and Turkey, because of its scent and visual beauty. *R. damascena* flowers have been widely used in perfume, medicine and food industries. In the context of traditional medicinal approaches, the flowers of *R. damascena* is worthy of attention due to its safe and efficacious history of administration in Persian medicine. *R. damascena* is a well-known medicinal plant regarding the beneficial effects in various diseases including gastrointestinal disease, cardiovascular disorders, wound healing and skin health, inflammatory diseases, menstrual bleeding, pregnancy-related disorders, as well as mental disorders particularly depression, nervous stress and tension.[@bib7], [@bib8], [@bib9], [@bib10] The flower of *R. damascena* has been claimed to be useful for liver dysfunction and have liver tonic properties in the literatures of Persian medicine.[@bib11]

A wide range of phytochemical ingredients were isolated from hips, petals and flowers of *R. damascena* containing flavonoids, glycosides, terpenes, and anthocyanins. The major active constituent of *R. damascena* is phenolic compounds including kaempferol, quercetin, gallic acid, cyanidin 3, 5, D-glycoside.[@bib12] β-citronellol, nonadecane, geraniol, nerol, and kaempferol are the main chemical constituents of volatile oil of *R. damascena* flower.[@bib13] Galactoside, xyloside, galactoside, rutinoside, and arabinoside are among glycoside component of this plant.[@bib12] In addition, carboxylic acid, myrcene, azlyn, linalool, geraniol, and vitamin C are other identified compounds of *R. damascena*.[@bib9], [@bib14] The present study was conducted to investigate the efficacy of standardized extract of *R. damascena* in experimental model of NAFLD and revealing the potential mechanisms.

2. Material and method {#sec2}
======================

2.1. Chemical and reagents {#sec2.1}
--------------------------

Reagent kits for triglyceride (TG), cholesterol (Chol), high-density lipoprotein (HDL), low-density lipoprotein (LDL), alanine aminotransferase (ALT), and aspartate transaminase (AST) were supplied from (Sigma-Aldrich, Steinheim, Germany). We obtained other chemicals, unless otherwise stated, from Sigma Chemicals Co. (St. Louis, MO, USA).

2.2. Plant material and extraction {#sec2.2}
----------------------------------

*R. damascena* flowers were collected in July 2015 from local herbal store of Tehran and authenticated and a voucher specimen \[No: PMP-507\] was deposited in the herbarium of Faculty of Pharmacy, Tehran University of Medical Sciences. The flowers were shade-dried at room temperature and ground into coarse particles. To prepare hydroalcoholic extract, 700 g of the plant powder were extracted three times with 70% ethanol. Each extracted solution was filtered and evaporated to dryness at 40 °C to yield residues about 19.65%. *R. damascena* hydroalcoholic extract (RHE) was standardized based on three polyphenols (syringic acid, gallic acid and quercetin) using HPLC method as previously described.[@bib15]

2.3. Animal models and experimental design {#sec2.3}
------------------------------------------

Male 10-weeks-old Wistar-albino rats, weighing (300--350 g) were accommodated under standard conditions of temperature (20--25 °C), 12 h light/dark cycle, and relative humidity (55± 10%), enough attainment to food (standard pellet) and water *ad libitum*. All animal practices were carried out base on the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health which were approbated by ethical committee of Tehran University of Medical Sciences.

42 rats were randomly separated to seven groups of six per each. One group received routine diet as normal. Other groups were fed with high fat diet (HFD) containing 83% of basal fodder, 10% of lard, 5% egg yolk powder, and 2% of cholesterol for a period of 8 weeks. After two weeks of study, HFD groups were planned to receive vehicle (distilled water), simvastatin (as positive control) as well as 25, 50, 100 and 200 mg kg^−1^ day^−1^ of RHE. Orally treatment was administered every 24 h for 6 weeks. We measured body weights every week. The last day of the study, blood samples of sacrificed rats collected from abdominal aorta for the measurement of TC, LDL, HDL, TG, ALT, and AST.

2.4. Evaluation of oxidative stress biomarkers {#sec2.4}
----------------------------------------------

Blood samples were collected into tubes containing EDTA and were centrifuged at 3000 *g* for 15 min for evaluating oxidative stress biomarkers. For determining the following biomarkers, separated plasma was kept at −80 °C.

2.5. Myeloperoxidase (MPO) {#sec2.5}
--------------------------

Defrosted plasma and 50 mM phosphate buffer containing 0.167 mg/ml o-dianisidine hydrochloride and 0.0005% H~2~O~2~ was mixed. Afterward, we recorded the absorbance at 460 nm for 3 min using a UV-visible spectrophotometer (GBC, Cintra 40). The definition of one unit of MPO activity is the change in absorbance per min at room temperature, in the final reaction.

2.6. Lipid peroxidation (LPO) {#sec2.6}
-----------------------------

LPO was evaluated using thiobarbituric acid reactive substances assay. Trichloroacetic acid (20%) was reacted with blood samples and the residual was mixed with a solution of 0.05 M H~2~SO~4~. Then, in a boiling water bath, 2-thiobarbituric acid was added followed by 30 min incubation. *n*-butanol was used to extract the mixture and absorbance was recorded at 532 nm (ELISA reader, Biotek, Germany).[@bib16]

2.7. Total thiol molecule (TTM) {#sec2.7}
-------------------------------

In order to assess levels of plasma TTM, 5′5′ dithiobisnitrobenzoic acid (DTNB) was reacted with blood samples to create a yellow complex. The absorbance was measured by spectrophotometry at 412 nm.[@bib17]

2.8. Ferric reducing ability of plasma (FRAP) {#sec2.8}
---------------------------------------------

We measured FRAP by using fresh FRAP reagent (25 mL of 0.3 M acetate buffer, 2.5 mL of TPTZ solution, and 2.5 mL of FeCl~3~·6H2O solution) mixed with defrosted plasma samples and absorbance was recorded at 593 nm.[@bib18]

2.9. Histopathological analysis {#sec2.9}
-------------------------------

For evaluating the histopathological analysis, the fixed segments in formalin 10% were embedded in paraffin and stained with hematoxylin and eosin to detect hepatic steatosis, inflammation and necrosis. A blind pathologist performed the histological evaluation.

2.10. Statistical analysis {#sec2.10}
--------------------------

Data were analyzed by SPSS (SPSS Inc., Chicago, Ill., USA). We used One-way ANOVA followed by Newman--Keul\'s post hoc test for multiple comparisons. The *p* values less than 0.05 were considered significant. Results are expressed as mean ± standard error of the mean (SEM).

3. Results {#sec3}
==========

3.1. Effect of RHE on weight gain and lipid profile {#sec3.1}
---------------------------------------------------

HFD fed animals had significantly higher weight gain compared with normal diet group. Weight gain was reduced by all doses of RHE as well as simvastatin in comparison with rats treated with HFD plus vehicle (*p* \< 0.05, [Table 1](#tbl1){ref-type="table"}).Table 1Effect of *R. damascena* extract on body weights of rats with fatty liver induced by HFD.Table 1GroupsBody weight (g)Normal326.5 ± 16.03HFD-fed + V367.33 ± 12.41[a](#tbl1fna){ref-type="table-fn"}HFD-fed + Simvastatin (20 mg/kg)337.16 ± 16.75[b](#tbl1fnb){ref-type="table-fn"}HFD-fed + RHE 25 mg kg^−1^ day^−1^350.33 ± 22.50[a](#tbl1fna){ref-type="table-fn"}HFD-fed + RHE 50 mg kg^−1^ day^−1^348.33 ± 18.59[a](#tbl1fna){ref-type="table-fn"}^,^[b](#tbl1fnb){ref-type="table-fn"}HFD-fed + RHE 100 mg kg^−1^ day^−1^342.83 ± 17.21[b](#tbl1fnb){ref-type="table-fn"}HFD-fed + RHE 200 mg kg^−1^ day^−1^335.83 ± 13.79[b](#tbl1fnb){ref-type="table-fn"}[^1][^2][^3]

[Table 2](#tbl2){ref-type="table"} demonstrates lipid profile changes in different groups of animals. TG, TC and LDL-C plasma levels were significantly lower in normal animals compared with HFD diet rats; however, HDL-C was significantly higher in normal rats. TG level was significantly reduced compared to vehicle treated HFD animals by using different doses of RHE as well as simvastatin (*p* \< 0.05). In addition, all doses of RHE treatment reduced TC and LDL-C plasma levels compared to negative control. Higher doses of RHE demonstrated numerically better activity in regulation of lipid profile parameters. Regarding HDL-C levels, all doses of RHE except 25 mg/kg were able to induce a significant increase compared to vehicle treated animals.Table 2Alterations on the plasma lipid parameters in HFD-fed rats treated with *R. damascena* extract for 8 weeks.Table 2GroupsTG (mg.dl^−1^)Chol (mg.dl^−1^)LDL (mg.dl^−1^)HDL (mg.dl^−1^)Normal79.5 ± 5.3193.5 ± 6.7147.95 ± 6.3550.5 ± 4.88HFD-fed + V132.5 ± 9.71[a](#tbl2fna){ref-type="table-fn"}164.5 ± 8.5[a](#tbl2fna){ref-type="table-fn"}126.26 ± 7.18[a](#tbl2fna){ref-type="table-fn"}35.83 ± 5.49[a](#tbl2fna){ref-type="table-fn"}HFD-fed + Simvastatin (20 mg/kg)82.66 ± 4.17[b](#tbl2fnb){ref-type="table-fn"}102.83 ± 8.86[b](#tbl2fnb){ref-type="table-fn"}52.53 ± 6.48[b](#tbl2fnb){ref-type="table-fn"}46.83 ± 5.03[b](#tbl2fnb){ref-type="table-fn"}HFD-fed + RHE 25 mg kg^−1^ day^−1^97.83 ± 5.41[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}138.16 ± 4.49[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}84.56 ± 7.08[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}39.83 ± 6.61[a](#tbl2fna){ref-type="table-fn"}HFD-fed + RHE 50 mg kg^−1^ day^−1^92.16 ± 7.73[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}135.33 ± 8.16[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}79.21 ± 5.52[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}41.66 ± 6.25[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}HFD-fed + RHE 100 mg kg^−1^ day^−1^90.66 ± 7.61[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}130.16 ± 8.95[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}66.65 ± 4.46[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}42.83 ± 3.76[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}HFD-fed + RHE 200 mg kg^−1^ day^−1^87.66 ± 7.11[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}125.5 ± 9.33[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}57.48 ± 7.85[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}44.5 ± 5.89[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}[^4][^5][^6]

3.2. Effect of RHE on hepatic enzymes {#sec3.2}
-------------------------------------

As shown in [Fig. 1](#fig1){ref-type="fig"}, HFD group treated with vehicle had significant elevation of ALT and AST plasma levels; but, these levels were reduced by using simvastatin and different doses of RHE in dose dependent manner (*p* \< 0.05).Fig. 1AST and ALT values in animals with fatty liver induced by HFD. Values are mean ± SEM. V: vehicle (distilled water); DW: distilled water; HFD: high fat diet; RHE: *R. damascena* hydroalcoholic extract; SV: simvastatin. ^a^Significantly different from the normal group at *p* \< 0.05. ^b^Significantly different from the HFD-fed + V group at *p* \< 0.05.Fig. 1

3.3. Effect of RHE on biomarkers of oxidative damage {#sec3.3}
----------------------------------------------------

As demonstrated in [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}, HFD resulted in remarkable oxidative damage in animal with NAFLD treated with vehicle. Oxidative stress-associated parameters were apparently modulated by utilizing different doses of RHE. MPO activity was significantly suppressed by applying RHE in a dose dependent manner ([Fig. 2](#fig2){ref-type="fig"}). Likewise, all doses of RHE reduced the elevated level of LPO ([Fig. 3](#fig3){ref-type="fig"}). Treatment with 200 mg/kg dose of RHE showed significantly the best effect on TIM ([Fig. 4](#fig4){ref-type="fig"}). In addition, all doses of RHE could remarkably increase FRAP value ([Fig. 5](#fig5){ref-type="fig"}).Fig. 2MPO (myeloperoxidase) values in animals with fatty liver induced by HFD. Values are mean ± SEM. DS: Distilled water; HFD: high fat diet; RHE: *Rosa damascena* extract; SV: simvastatin. ^a^Significantly different from the normal group at *p* \< 0.05. ^b^Significantly different from the HFD-fed + DS group at *p* \< 0.05.Fig. 2Fig. 3LPO (lipid peroxidation) values in animals with fatty liver induced by HFD. Values are mean ± SEM. DS: Distilled water; HFD: high fat diet; RHE: *Rosa damascena* extract; SV: simvastatin. ^a^Significantly different from the normal group at *p* \< 0.05. ^b^Significantly different from the HFD-fed + DS group at *p* \< 0.05.Fig. 3Fig. 4Total thiol values in animals with fatty liver induced by HFD. Values are mean ± SEM. DS: Distilled water; HFD: high fat diet; RHE: *Rosa damascena* extract; SV: simvastatin. ^a^Significantly different from the normal group at *p* \< 0.05. ^b^Significantly different from the HFD-fed + DS group at *p* \< 0.05.Fig. 4Fig. 5FRAP (Ferric reducing ability of plasma) values in animals with fatty liver induced by HFD. Values are mean ± SEM. DS: Distilled water; HFD: high fat diet; RHE: *Rosa damascena* extract; SV: simvastatin. ^a^Significantly different from the normal group at *p* \< 0.05. ^b^Significantly different from the HFD-fed + DS group at *p* \< 0.05.Fig. 5

3.4. Effect of RHE on liver histology {#sec3.4}
-------------------------------------

Liver sections evaluated histologically in order to confirm the efficacy of RHE on hepatic steatosis. [Fig. 6](#fig6){ref-type="fig"}A demonstrates liver tissue of a normal rat in which large, round and fairly euchromatic and nuclei with no inflammatory cells were appeared. A higher level of steatosis was seen in animals fed with HFD for 8 weeks ([Fig. 6](#fig6){ref-type="fig"}C). Liver steatosis was determined by staining (hematoxylin-eosin) of the liver tissue. Severe fat vacuoles accumulation in the cytoplasmic of hepatocytes, steatohepatitis and pericentral necrosis as well as scattered inflammatory cell infiltration was represented in animals fed with HFD ([Fig. 6](#fig6){ref-type="fig"}C). As represented in [Fig. 6](#fig6){ref-type="fig"}B, limited symptoms of fatty change in liver cells of the simvastatin group indicate that the drug prevents the accumulation of triglycerides within hepatocytes. Steatohepatitis and necrosis were obviously suppressed by applying RHE treatment ([Fig. 6](#fig6){ref-type="fig"}D).Fig. 6Histological images of liver tissues obtained from animal groups. The liver sections were stained with hematoxylin and eosin (H & E), and the magnification is 40. A: Microscopic evaluation of normal group show large, round and fairly euchromatic and nuclei with no inflammatory cells. Black arrow shows normal centrilobular vein. Normal sinusoids are shown by blue arrows. Green arrow shows portal triad. Orange arrow shows normal hepatocyte. B: Histological images of liver tissues obtained from HFD-fed simvastatin group, no signs of fatty change in liver cells indicating that the drug prevents the accumulation of triglycerides within hepatocytes, inspite of heavy lipids fed. Hepatocytes have large, round and fairly euchromatic and nuclei with acidophilic cytoplasm. Some cells are degenerated or without nuclei. Kupffer cells count is more than normal. Black arrow shows normal centrilobular vein. Normal sinusoids are shown by blue arrows. Green arrow shows portal triad. Orange arrow shows hepatocyte. C: Microscopic evaluation of the HFD-fed control group showed intense hepatic steatosis, pericentral necrosis and abundant inflammatory cells. Severe fat vacuoles accumulation in the cytoplasmic of hepatocytes and vacuolar hepatocyte degeneration as well as numerous kupffer cells infiltration are seen. Sinusoids and centrilobular veins are dilated. . Black arrow shows dilated centrilobular vein. Dilated sinusoids are shown by blue arrows. Green arrow shows portal triad. Orange arrows show hepatocyte. D: Histological examination of liver tissues obtained from HFD-fed RHE (200 mg/kg) treated group, lipid accumulation within cytoplasm of hepatocytes were considerably diminished comparing to untreated group. Black arrow shows dilated centrilobular vein. Normal sinusoids are shown by blue arrows. Green arrow shows portal triad.Fig. 6

4. Discussion {#sec4}
=============

Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease and its prevalence has approximately doubled in the past decade with the growing epidemic of obesity.[@bib19] NAFLD is highly correlated with the so-called metabolic syndrome, along with diabetes, hypertension, atherosclerosis, hypertriglyceridemia and obesity. Unhealthy dietary habits and high calorie diets are among the most important risk factors. On the other hand, several studies showed that Mediterranean diet, applying various herbs and taking unsaturated fatty acids, reduce prevalence and/or severity of liver diseases including NAFLD.[@bib20] NAFLD is associated with insulin resistance and hyperinsulinemia leading to a resistance in the antilipolytic effect of insulin in the adipose tissue with an increase of free fatty acids.[@bib21], [@bib22]

There are limited conventional drugs for NAFLD which have different adverse effects; therefore, herbal remedies with lipid-lowering and antioxidant as well as anti-inflammatory activities can play a beneficial role for the management of the disease.[@bib23]

*R. damascena* has been traditionally used in various diseases including gastrointestinal disease.[@bib9] The fresh juice of *R. damascena* exhibited antioxidant potential effects in vitro.[@bib24] Current study confirmed the efficacy of RHE in animal model of NAFLD. In this study, NAFLD was induced by a high fat diet and the outcome of treatment with RHE on gaining weight as well as lipid profile in treated animals was evaluated. All doses of RHE could moderate lipid plasma levels in rats under HFD diet compared with vehicle treated animals. RHE and simvastatin treatment could suppress AST and ALT levels. Beneficial effects of RHE treatment in NAFLD is also evaluated in histopathological studies.

An important risk factor in pathogenesis of NAFLD is oxidative stress. It has been shown that oxidation of cytotoxic free fatty acids cause by chronic oxidative stress, may lead to up regulation of cytokine and depletion of hepatic antioxidant levels.[@bib25] Free radicals are nowadays known as one of the prime suspects of inflammation and tissue damage in many chronic disorders, including liver diseases.[@bib26], [@bib27] Products of lipid peroxidation such as malondialdehyde, GGT and oxidized LDL which are increased in NAFLD patients may be related to decreased antioxidants.[@bib28] Therefore, applying antioxidant supplementations may play an important role and one of the current pharmacological treatments for NAFLD. Previous study by Memariani et al for the determination of phenolic components from flowers of *R. damascena* using HPLC analysis resulted in detection and quantification of three phenolic compounds including gallic acid (118.213 ± 0.12 mg/g dried extract), quercetin (12.86 ± 0.31 mg/g dried extract), and syringic acid (3.48 ± 0.19 mg/g dried extract).[@bib15] Determination of these polyphenols with HPLC analysis was executed for standardization of RHE.

Evaluation of biomarkers of oxidative damage in NAFLD animals treated with RHE extract showed significant suppression in MPO and LPO levels. In addition, TTM and FRAP value were remarkably higher in animals treated with the extract. Another species of the same genus, *Rosa laevigata* Michx showed hepatoprotective effects in rat model of CCl4-induced liver fibrosis through modulating inflammatory process and suppressing oxidative mediated by regulating TGF-β/Smad and mitogen-activated protein kinases (MAPK) signaling. Likewise, down-regulation of TNF-α level has a significant role in the hepatoprotective activity of total flavonoid extract from fruit of *R. laevigata* Michx.[@bib29], [@bib30] High amount of phenolic compounds possess a pivotal contribution in therapeutic potential of this natural preparation in NAFLD animals. Phenolic compounds identified in standardized extract of RHE are well-known antioxidant agents which have demonstrated beneficial effects in several pathologic conditions, including hepatic injuries.[@bib31], [@bib32], [@bib33] A wide range of experimental studies confirm the efficacy of phenolic compounds in the treatment of NAFLD via numerous biological mechanisms including ant-oxidative stress activity, inhibition of pro-inflammatory cytokines, and modulatory effect on inflammatory signaling pathways.[@bib31] In addition, investigations revealed the beneficial effects of gallic acid -- one of the main phenolics of RHE -- in paracetamol induced hepatotoxicity through suppression of lipid peroxidation and anti-inflammatory activity via decreasing TNF-α.[@bib34] Moreover, Oxygen radical absorbance capacity of plasma and the level of phenol sulfotransferase were significantly increased in rats treated with gallic acid and *p*-coumaric acid.[@bib35] Gallic acid also attenuated steatohepatitis, hypercholesterolemia, weight gain, as well as insulin resistance via modulation of glycolysis, gluconeogenesis and metabolism of amino acids and choline in mice with NAFLD induced by high fat diet.[@bib36] Chronic dietary intake of quercetin could suppress cholesterol and liver fat accumulation and improved systemic parameters related to metabolic syndrome, probably mainly through decreasing oxidative stress, by suppressing TNFα, hepatic thiobarbituric acid-reactive as well as peroxisome proliferator-activated receptor (PPAR)-α expression[@bib37]. The beneficial effects of RHE in experimental NAFLD could be explained by considering the presence of these phenolic compounds with obvious antioxidant and hepatoprotective properties.

5. Conclusion {#sec5}
=============

*R. damascena* from the family Rosaceace is a traditionally used medicinal plant which has demonstrated beneficial effects in several gastrointestinal complications. Current study demonstrated positive effects of *R. damascena* as a dietary supplement and an alternative medicine in the management of NAFLD. *R. damascena* significantly reduced the elevations of serum TG, cholesterol, LDL, and hepatic enzymes. Improvement of antioxidant status as well as hepatoprotective activity mediated by phenolic ingredients are among the main potential mechanisms of action of this natural remedy. Since this plant is well-known and safe so could be a candidate as an adjuvant therapy along with conventional pharmacological treatments for future human studies in patients suffering from NAFLD.
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[^1]: Values are mean ± SEM. HFD: high fat diet; RHE*: R. damascena* hydroalcoholic extract; V: vehicle.

[^2]: Significantly different from the normal group at *p* \< 0.05.

[^3]: Significantly different from the HFD-fed + V at *p* \< 0.05.

[^4]: Values are mean ± SEM. V: vehicle; HFD: high fat diet; RHE: *R. damascena* hydroalcoholic extract.

[^5]: Significantly different from the normal group at *p* \< 0.05.

[^6]: Significantly different from the HFD-fed + V group at *p* \< 0.05.
